There is a growing body of evidence that the N-terminal domain may have a role in tumor suppression [6,35,36] and our work highlights its importance in the regulation of ESR1 activity with a direct consequence in the response of breast cancer therapy. This evidence concerns the gene ESR1 and breast cancer.